News – Page 353 – Endpoints News

In victory for microbiome company, FDA approves pills purified from poop

3 years ago

Early results from Alzheimer’s study set stage for Alnylam’s expansion into brain diseases

3 years ago

Giovanni Caforio to step down as Bristol Myers CEO, with Chris Boerner named successor

3 years ago

Following CRL, Form 483 reveals more quality issues at Alvotech’s production facility in Iceland

3 years ago

Ahead of adcomm, FDA raises concerns about plan to expand Lynparza's use in prostate cancer

3 years ago

GSK's new RSV campaign lands in advance of FDA decision set for next week

3 years ago

As showdown with activist nears, Illumina’s CEO defends the company’s $7.1B purchase of Grail

3 years ago

Bristol Myers snaps up former Novartis manufacturing site in Illinois

3 years ago

FDA issues warning letter to another manufacturer over possible glycol contamination

3 years ago

Europe faces a major new overhaul of its 20-year-old pharma legislation

3 years ago

Roche's portfolio 'rejuvenation' fuels 9% increase in drug sales, led by eye treatment

3 years ago

After a patient death in NKT trial, Athenex hires chief restructuring officer

3 years ago

Novartis' PNH drug succeeds in PhIII and will go to FDA, setting up battle with AstraZeneca

3 years ago

Evelo again misses primary goal in atopic dermatitis and will shutter study, lay off more staff

3 years ago

South Dakota-based Covid-19 transgenic cow antibody startup claims its first PhIII win

3 years ago

GSK ends PhIII Zejula trial after running into challenges enrolling patients

3 years ago

Evommune raises $50M to fund clinical trials in skin diseases

3 years ago

Finch Therapeutics brings on new CEO, CFO after January layoffs and scrapping a PhIII trial

3 years ago

Roche's Q1 pipeline cleanup claims PhII myelofibrosis drug, early-stage MAGE-A4 work

3 years ago

CAR-T reshaped cancer treatment. Can it change autoimmune disease, too?

3 years ago

With $270M, Beam spinoff Orbital Therapeutics builds RNA medicines as it hunts for partners, more delivery tech

3 years ago

With proxy fight deadline a month away, Illumina announces plans to cut $100M in costs

3 years ago

More than two dozen Democrats introduce bill to extend CMS drug price negotiations farther

3 years ago

Biogen CEO in search for 'external growth' to boost pipeline as revenue falls

3 years ago

First page Previous page 350 351 352353354 355 356 Next page Last page